A Comparison of Death Domain-Associated Protein 6 in Different Endometrial Carcinomas Histotypes.

Conclusions: We demonstrate that loss of nuclear DAXX is present in low-grade endometrial carcinomas and the differentiated components in UEC/DDEC, but not in high-grade ones, suggesting DAXX's role in tumor progression and its potential as a therapeutic target in high-grade endometrial carcinomas. PMID: 31384126 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31384126?dopt=Abstract

Source: Biomarker Insights - August 8, 2019 Category: General Medicine Authors: Jin C, Hacking S, Komforti MK, Nasim M Tags: Biomark Insights Source Type: research